Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

[Bis(quinoline)palladium (II) Chloride] as an Anticancer Drug Demonstrates Promising Activity on Its Own and in the Presence of 6-Shogaol

Version 1 : Received: 3 August 2023 / Approved: 4 August 2023 / Online: 4 August 2023 (07:24:51 CEST)

How to cite: Alam, M. N.; Almoyad, M. A. A.; Yu, J. Q.; Beale, P.; Proschogo, N.; Rupon, F. A.; Shahriar, M.; Huq, F. [Bis(quinoline)palladium (II) Chloride] as an Anticancer Drug Demonstrates Promising Activity on Its Own and in the Presence of 6-Shogaol. Preprints 2023, 2023080381. https://doi.org/10.20944/preprints202308.0381.v1 Alam, M. N.; Almoyad, M. A. A.; Yu, J. Q.; Beale, P.; Proschogo, N.; Rupon, F. A.; Shahriar, M.; Huq, F. [Bis(quinoline)palladium (II) Chloride] as an Anticancer Drug Demonstrates Promising Activity on Its Own and in the Presence of 6-Shogaol. Preprints 2023, 2023080381. https://doi.org/10.20944/preprints202308.0381.v1

Abstract

Synthesis and antitumour activity of a palladium compound, [Bis (quinoline) palladium (II) chloride] (coded as NH1) alone and in combination along with its proposed mechanism of action has been described in the present study. Antitumour activity has been performed in seven different cancer cell lines using colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. The investigated palladium compound demonstrated superiority over clinical standard cisplatin against drug resistant ovarian cancer cell lines. NH1 also demonstrates 4.4 times greater activity than cisplatin against breast cancer model. Binary sequenced combination study showed that NH1 in combination with curcumin is mostly additive to antagonistic. However, combination of NH1 with 6-shogaol demonstrated synergism depending on dose and sequence. Proteomic study revealed that changes in expression of 14 proteins were significantly associated with anticancer mechanism of NH1. In vivo anticancer activity of NH1 at a dose of 0.75 mg/kg was also evaluated using Erlich Ascites Carcinoma (EAC) cell lines in Swiss-albino mice model. Preliminary toxicity study in Swiss-albino mice proved that NH1 is comparatively less toxic at both of the administered doses, either 2.5 mg/kg or 5 mg/kg. However, cisplatin demonstrated significant toxicity at both of the administered doses. Biochemical investigations also supported that NH1 demonstrated lesser toxicity profile towards liver or kidney compared to clinical standard cisplatin.

Keywords

cancer; palladium; quinoline; curcumin; 6-shogaol; proteomics

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.